CYCC – cyclacel pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results [Yahoo! Finance]
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) had its price target lowered by analysts at Roth Mkm from $21.00 to $11.00. They now have a "buy" rating on the stock.
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules [Yahoo! Finance]
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
Form DEFA14A Cyclacel Pharmaceuticals
Form ARS Cyclacel Pharmaceuticals For: Dec 31
Form DEF 14A Cyclacel Pharmaceuticals For: Jun 21
Form S-1 Cyclacel Pharmaceuticals
Form 8-K Cyclacel Pharmaceuticals For: Apr 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.